HIV and aerobic exercise. Current recommendations

Sports Medicine

Volumn 28, Issue 6, 1999, Pages 389-395

  Stringer, William W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

AEROBIC CAPACITY; EXERCISE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; LACTIC ACIDOSIS; LEAN BODY WEIGHT; QUALITY OF LIFE; REVIEW; TRAINING;

EID: 0033391012     PISSN: 01121642     EISSN: None     Source Type: Journal    
DOI: 10.2165/00007256-199928060-00002     Document Type: Review

References (47)

1. 1. Eichner ER, Calabrese LH. Immunology and exercise: physiology, pathophysiology, and implications for HIV infection. Med Clin North Am 1994; 78: 377-88
2. 2. Newsholme EA, Parry-Billings M. Effects of exercise on the immune system. In: Bouchard C, Shephard RJ, Stephens T, editors. Physical activity, fitness, and health. Champaign (IL): Human Kinetics, 1994: 451-5
3. 3. LaPerriere A, Ironson G, Antoni MH, et al. Exercise and psychoneuroimmunology. Med Sci Sports Exerc 1994; 26: 182-90
4. 4. Cannon JG. Exercise and resistance to infection. J Appl Physiol 1993; 74: 973-81
5. 5. Chesney MA, Folkman S. Psychological impact of HIV disease and implications for intervention. Psychiatr Clin North Am 1994; 17: 163-82
6. 6. Birk TJ. HIV and exercise. Exerc Immunol Rev 1996; 2: 84-95
7. 7. Shephard RJ, Shek PN. Exercise and CD4+/CD8+ cell counts: influence of various contributing factors in health and HIV infection. Exerc Immunol Rev 1996; 2: 65-83
8. 8. Fletcher GF, Ballady G, Blair SN, et al. Statement on exercise: benefits and recommendations for physical activity programs for all americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1996; 94; 857-62
9. 9. Albanes DA, Blair A, Taylor P. Physical activity and risk of cancer in the NHANES I population. Am J Public Health 1989; 79: 744-50
10. 10. Pate RR, Pratt M, Blair SN, et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 402-7
11. 11. Fauci AS. Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996; 124: 654-63
12. 12. Castro KG, Ward JW, Slutsker JW, et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41: 961-2
13. 13. Choi S, Lagakos SW, Schooley RT, et al. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine [abstract]. Ann Intern Med 1993; 118: 674-80
14. 14. Fei DTW, Paxton H, Chen AB. Difficulties in precise quantitation of CD4+ T lymphocytes for clinical trials: a review. Biologicals 1993; 21: 221-31
15. 15. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitation of HIV-I RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122: 573-9
16. 16. Mulder J, McKinney N, Christopherson C, et al. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994; 32: 292-300
17. 17. Lee TH, Sheppard HW, Reis M, et al. Circulating HIV-I infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. J Acquir Immune Defic Syndr 1994; 7: 381-8
18. 18. O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-I RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996; 334: 426-31
19. 19. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. 1999. Available from http://hiv.medscape. com/govmt/dhhs/1998/1298/hivguidelines/hiv98-01.html [Accessed 1999 Nov 1]
20. 20. Johnson J, Anders G, Blanton H, et al. Exercise dysfunction in patients seropositive for the human immunodeficiency virus-1. Am Rev Respir Dis 1990; 141: 618-22
21. 21. Dalakas MC, Illa I, Pezeshkpour MD, et al. Mitochondrial myopathy caused by long term Zidovudine therapy. N Engl J Med 1990; 322: 1098-105
22. 22. Barbara G, Di Lorenzo G, Grisorio B, et al. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV+ patients. N Engl J Med 1998; 339: 1093-9
23. 23. Antoni MH, Schneiderman H, Fletcher MA, et al. Psychoneuroimmunology and HIV-I. J Consult Clin Psychol 1990; 58: 38-49
24. 24. Rigsby LW, Dishman RK, Jackson AW, et al. Effects of exercise training on men seropositive for the human immunodeficiency virus-I. Med Sci Sports Exerc 1992; 24: 6-12
25. 25. MacArthur RD, Levine SD, Berk TJ. Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons. Med Sci Sports Exerc 1993; 25: 684-8
26. 26. Pothoff G, Wasserman K, Ostmann H. Impairment of exercise capacity in various groups of HIV-infected patients. Respiration 1994; 61: 80-5
27. 27. Stringer WW, Berezovskaya M, O'Brien WA, et al. The effect of exercise training on aerobic fitness, immune indices, and quality of life in HIV+ patients. Med Sci Sports Exerc 1998; 30: 11-6
28. 28. Perna FM, LaPerriere A, Klimas NG, et al. Cardiopulmonary and CD4 changes in response to exercise training in early symptomatic HIV infection. Med Sci Sports Exerc 1999; 31: 973-9
29. 29. LaPerriere A, Klimas NG, Fletcher MA, et al. Change in CD4+ cell enumeration following aerobic exercise in HIV disease: possible mechanisms and practical applications. Int J Sports Med 1997; 18: S56-61
30. 30. Ullum H, Palmo J, Halkjaer-Kristensen J, et al. The effect of acute exercise on lymphocyte subsets, natural killer cells, proliferative responses, and cytokines in HIV seropositive persons. J Acquir Immune Defic Syndr 1994; 7: 1122-33
31. 31. Raboud JM. Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: S67-73
32. 32. LaPerriere A, Fletcher MA, Antoni MH, et al. Aerobic exercise training in an AIDS risk group. Int J Sports Med 1991; 12: S53-7
33. 33. Calabrese LH, LaPerriere A. Human immunodeficiency virus infection, exercise, and athletics. Sports Med 1993; 15: 6-13
34. 34. Mahler DA. ACSM's guidelines for exercise testing and prescription. Hagerstown (MD): Lippincott, Williams & Wilkins, 1995
35. 35. Smith BA, Neidig J, Nickel J, et al. Effects of aerobic and resistive exercise on symptoms, immune status, and viral load in HIV+ men and women [abstract]. Int Conf AIDS 1996; 11: 23
36. 36. Grinspoon S, Corcoran C, Rosenthal D, et al. Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome. J Clin Endocrinol Metab 1998; 84: 201-6
37. 37. Miller K, Corcoran C, Armstrong C, et al. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab 1998; 83: 2717-25
38. 38. Wagner G, Rabkin J, Rabkin R. Exercise as a mediator of psychological and nutritional effects of testosterone therapy in HIV+ men. Med Sci Sports Exerc 1998; 30: 811-7
39. 39. Grinspoon S, Corcoran C, Askari H, et al. Effects of androgen administration in men with AIDS wasting syndrome: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998; 129: 18-26
40. 40. Schambelan M, Mulligan K, Grunfeld C, et al. Recombinant human growth hormone in patients with HIV: associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med 1996; 125: 873-82
41. 41. Mulligan K, Tai VW, Schambelan M. Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus: associated wasting. A clinical research center study. J Clin Endocrinol Metab 1998; 83: 1542-7
42. 42. Ellis KJ, Lee PD, Pivarnik JM, et al. Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone. J Clin Endocrinol Metab 1996; 81: 3033-8
43. 43. Human immunodeficiency virus and other blood-borne pathogens in sports: the American Medical Society for Sports Medicine (AMSSM) and the American Academy of Sports Medicine (AASM) Joint Position Statement. Clin J Sport Med 1995; 5: 199-204
44. 44. Goldsmith M. When sports and HIV share the bill: smart money goes on common sense. JAMA 1992; 267: 1311-4
45. 45. Feller A, Flanigan TP. HIV-infected competitive athletes. What are the risks? What precautions should be taken? J Gen Intern Med 1997; 12: 243-6
46. 46. Exercises for people with HIV by people with HIV [video cassette]. Atlanta (GA): Positive Moves, 1997
47. 47. Mackinnon LT. Future directions in exercise and immunology: regulation and integration. Int J Sports Med 1998; 19: S205-9